Enavate Sciences GP, LLC → Zenas BioPharma, Inc. ZBIO

Stake: 7.30% Shares: 3,919,159 CUSIP: 98937L105 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 7.48

9,362,107 shares short · +21.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $10.48M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-28	MOULDER LEON O JR	director, officer	Buy	25,000	$18.02	$451K

Other Filings by Enavate Sciences GP, LLC

Filed	Form	Issuer	Stake	Shares
2025-09-15	SCHEDULE	Camp4 Therapeutics Corp CAMP	8.10%	3,785,802	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →